ORANGE, Calif., Nov. 21, 2025 /PRNewswire/ — Happyrun, one of America’s trusted high-performance electric bike brands, is offering instant savings of up to $2600 on the combo high-performance Happyrun G300 Pro electric dirt bike for Black Friday (November 3 – December 2025). Riders will also receive a complimentary gift bundle valued at over $280. Several other model combos are included in this year’s promotion, featuring savings up to $2,650 and bonus accessory bundles worth more than $800.

Whether you’re conquering rugged trails on electric dirt bikes, commuting daily on fat-tire e-bikes, or taking weekend adventures with electric cargo bikes, Happyrun makes premium riding more accessible than ever. This Black Friday, get unbeatable value on a Happyrun electric bike—giving you the power and performance you need as you head into 2026.

The G300 Pro electric dirt bike is Happyrun’s top off-road performer, engineered for riders who want true motorcycle-level excitement. It goes far beyond a typical e-bike, delivering the thrill, torque, and capability of a real off-road machine.

Key Features:

• Peak 6500W delivers powerful torque
• Reaches a top speed of 50 mph with precise handling
• Provides a 70-mile range for uninterrupted riding
• Features full front and rear suspension for a smooth ride
• Offers 19-inch front and 17-inch rear wheels for exceptional traction

Speed matters—but confidence, control, and terrain-crushing capability matter just as much. The Happyrun G300 Pro electric dirt bike strikes the perfect balance, giving riders the power to dominate steep climbs, rocky paths, and back-country routes with ease.

Quick Look at Happyrun Ebike Black Friday Deals:

G100 Long-Range E-Bike: Now $1,099 (was $2,399) — Save $1,300 + Free accessory bundle worth over $100 (waterproof cover, combination lock, portable air pump)

G100 Pro Electric Motorcycle-Style E-Bike: Now $2,199 (was $3,299) — Save $1,100 + Free accessory bundle worth over $400 (LED helmet, rear rack, rearview mirrors, combination lock, air pump)

G300 Pro Electric Dirt Bike: Now $2,199 (was $3,499) — Save $1,300 + Free accessory bundle worth over $140 (gloves, phone holder, combination lock)

Combo G100 Long-Range E-Bike: Now $2,148 — Save $2,650 + Free accessory bundle worth over $200 (two sets: waterproof cover, combination lock, portable air pump)

Combo G100 Pro Electric Motorcycle-Style E-Bike: Now $4,298 — Save $2,300 + Free accessory bundle worth over $800 (two sets: LED helmet, rear rack, rearview mirrors, combination lock, air pump)

Combo G300 Pro Electric Dirt Bike: Now $4,398 — Save $2,600 + Free accessory bundle worth over $280 (two sets: gloves, phone holder, combination lock)

For additional deals, visit the Happyrun ebike website.

Happyrun — Your Trusted Companion for Every Ride

From the beginning, Happyrun has committed to a simple promise: make electric riding accessible, reliable, and enjoyable for everyone. Whether it’s the urban-friendly G100 or the trail-dominating G300 Pro, every model is built on the same foundation—performance without compromise.

Riders trust Happyrun not only for its high-quality engineering but also for its exceptional after-sales support and warranty coverage. From first-time e-bike owners to seasoned off-road enthusiasts, Happyrun ensures every journey starts with confidence.

Why Choose Happyrun for Black Friday

For this year’s Black Friday, Happyrun ebike delivers its strongest value yet across all electric dirt bikes and electric motorcycles.

What’s included:

• Save up to $2600 on electric dirt bikes
• Receive complimentary gifts valued at over $800
• Offer valid through December 2025 while supplies last.

If you’re ready to upgrade your ride—or buy your first e-bike—this is the best moment to join the Happyrun family.

Get Your Happyrun Ebike Today

When you choose a Happyrun, you’re not just buying a powerful electric bike—you’re investing in a brand dedicated to your riding experience. With full warranty coverage, dependable after‑sales support, and a team committed to rider satisfaction, Happyrun is with you every mile.

Shop Happyrun’s 2025 Black Friday deals now—save up to $2,600 and receive a complimentary gift package. From highways to off-road trails, Happyrun e-bikes are built to handle real-world adventure.

Don’t miss the extra $100 surprise discount! Use code BFCM100, and you can stack it with the offers above.

Get your Happyrun e-bike today and start your next chapter with power, confidence, and unbeatable value.

For more information, please visit:
US website: https://www.happyrunsports.com/
Facebook: https://www.facebook.com/happyrunsports
Facebook group: https://www.facebook.com/groups/happyrunebike/
YouTube: https://www.youtube.com/@happyrunsports
TikTok: https://www.tiktok.com/@happyrunsports
X: https://x.com/HappyRunSports
Instagram: https://www.instagram.com/happyrunsports/

RIYADH, Saudi Arabia, Nov. 21, 2025 /PRNewswire/ — The Future Minerals Forum (FMF), convened by the Ministry of Industry and Mineral Resources, today unveiled the full three-day program for its fifth and biggest edition, themed “Dawn of a Global Cause.” The Forum will take place in Riyadh from January 13 – 15, 2026, convening over 500 leaders from governments, multilateral organizations, and academia to shape the future of minerals.

Future Minerals Forum Unveils Three-Day Program for Its 5th Largest Edition

FMF 2026 will rally decision-makers around a shared ambition to advance responsible mineral development and create new economic opportunities in supplier and customer nations. The program combines high-level policy dialogue with practical investment and innovation sessions designed to accelerate progress across the global minerals ecosystem.

Program highlights include:

• 5^th edition of the world’s largest Ministerial Roundtable on minerals, with over 100 government representatives, more than 70 international organizations, and top industry CEOs.
• State of the Sector, in partnership with McKinsey, will unpack the inaugural Future Minerals Barometer Report, tracking sector trends, leadership sentiment, the industry’s reputation, and others.
• Inaugural Mineral Investment Journey dedicated, closed-door sessions for new and existing investors.
• Inaugural Gateway to Funding, in partnership with BMO, will connect institutional investors and family businesses with international mining companies seeking growth capital.
• Inaugural MinGen Workshops, a dynamic workshop for young professionals, women in mining, and leadership networking.

The Ministerial Roundtable, a high-level government-led meeting, will headline FMF26, setting the stage open for ensuing discussions and activities. “This dynamic and impact-driven platform is one of the key reasons governments and CEOs consistently return to FMF,” said Ali Al-Mutairi, FMF Executive Director.

Day one will host an International Exhibition and interactive Knowledge Exchange sessions, during which industry leaders will present insights into the global mineral supply outlook.  Days two and three will host Leadership Roundtables, including a series of Regional Leadership Roundtables for Africa, Latin America, and Central Asia, focusing on the opportunities for trade and investment to and from emerging supplier regions.

Among the global leaders confirmed to speak are Dominic Barton, Chairman, Rio Tinto; Bob Wilt, CEO, Maaden; Gustavo Pimenta, CEO, Vale; Catherine Raw, Chief Development Officer, BHP; and executives from other top-tier organizations.

FMF 2026 continues to cement Riyadh’s position as a global convening hub for mineral dialogues, investment, and innovation—toward a more sustainable and equitable minerals future.

SINGAPORE, Nov. 21, 2025 /PRNewswire/ — Subotiz, an emerging fintech platform powering AI-driven subscription and payment solutions, was recently featured at the Singapore FinTech Festival (SFF 2025), a global stage for innovation in finance and technology.

At SFF 2025, a participating exhibitor demonstrated advanced subscription and billing models using Subotiz’s technology in their on-site demos, giving attendees a real-time look at streamlined workflows, personalized experiences, and scalable revenue flows. The demonstration underscored Subotiz’s role in advancing more efficient subscription management and improved transaction performance for digital businesses worldwide.

Subotiz’s AI-powered payment orchestration layer combines dynamic payment routing, smart retry logic, and automated revenue recovery to maximize authorization rates and reduce churn. The platform supports multiple  gateways and alternative payment methods, providing compliance-ready settlement infrastructure that empowers global business expansion.

Offering a white-label option, the infrastructure enables partners to integrate Subotiz technology under their own branding. This flexibility enables payment providers, SaaS platforms, and digital aggregators to deliver customizable recurring payment systems without the need to develop proprietary platforms.

“Subotiz was designed to drive the next era of intelligent and globally connected subscription businesses,” said Ryan Yang, Solution Director of Subotiz. “It’s exciting to see our platform empowering partners to create smarter, more personalized, and efficient payment experiences worldwide.”

About Subotiz

Subotiz is a next-generation subscription and payment infrastructure platform designed for global digital businesses. By combining flexible subscription management, AI-powered automation, and robust compliance capabilities, Subotiz empowers businesses to scale their recurring revenue operations with intelligence and confidence. Subotiz operates independently with a global team bringing together deep expertise in payments, SaaS and AI innovation. Learn more at https://www.subotiz.com/.

Delivering high-performance, scalable infrastructure for AI, HPC, and enterprise workloads

KEY POINTS

• Fully scalable storage: Unified, block, file, object, and software-defined systems for AI, HPC, and enterprise workloads
• Next-gen AI power: XA AM3A-E13 with AMD Instinct MI355X GPUs delivers efficient, high-bandwidth generative-AI performance
• Ecosystem synergy: ASUS partners with Intel®, IBM, and Micron to advance next-gen AI data center innovations

SINGAPORE, Nov. 21, 2025 /PRNewswire/ — ASUS today announced an all-new lineup of enterprise and AI/HPC-optimized storage and infrastructure solutions at Supercomputing 2025 (SC25). Recognizing the escalating demands of scaling AI models and memory-intensive workloads, ASUS storage solutions are now a strategic imperative, critical for sustaining efficient AI data processing and managing rapidly expanding datasets. This launch further solidifies the company’s position as a total infrastructure provider, delivering an integrated ecosystem spanning compute, storage, networking, and services. ASUS, through its robust global supply chain and logistical capabilities, ensures consistent, reliable product delivery, establishing itself as a trusted partner for organizations deploying resilient and scalable AI environments.

Comprehensive storage solutions

ASUS delivers a full spectrum of storage solutions across block, file, object, and software-defined systems — ensuring flexibility from edge to cloud, and from enterprise applications to AI and HPC workloads. The portfolio supports storage for Enterprise and AI/HPC needs, providing resilient data foundations and scalable performance for data-driven environments.

• Block Storage – VS320D-RS12
  Featuring active-active controller design with Intel^® Xeon^® processors, these systems provide enterprise-grade reliability, scalable capacity up to 7.1PB, and high throughput through SSD caching and auto-tiering — ideal for virtualization and business-critical operations.
• Unified Storage – VS320D- RS12U
  Built for mixed enterprise workloads, this series supports multiple file and block protocols with advanced features such as SSD caching, auto-tiering, S3 cloud sync, DR site, and data reduction. Powered by Intel Xeon dual controller architecture, it ensures fast, efficient, and secure data access.
• Object Storage – OJ340A-RS60
  A scalable, AMD-based solution offering S3/Swift-compatible object storage on a Ceph framework. NVMe acceleration delivers predictable performance for AI data lakes, analytics, and long-term archiving at exabyte scale.
• JBOD Storage- VS320D-RS12J
  Optimized for high-density capacity expansion, the ASUS JBOD series provides up to 7.1 PB of scalable storage with 78 / 12-bay configurations. It supports 12 Gb/s SAS 3.0 interfaces, redundant power, and multipath connectivity, delivering flexible, reliable scalability for enterprise and data-center deployments.
• AI/HPC Storage
  Developed with WEKA, IBM, VAST Data, and Hammerspace, this AMD EPYC™ powered platform provides high-performance, software-defined storage for GPU-accelerated AI and HPC environments, combining low latency with unified data management.

ASUS XA AM3A-E13 Powered by AMD Instinct MI355X Debuts for Generative AI and HPC

Partnering with a broad ecosystem of technology leaders, a complete AI infrastructure lineup is being showcased at SC25. Within this comprehensive portfolio, ASUS is unveiling the XA AM3A-E13, powered by eight AMD Instinct™ MI355X GPUs and dual AMD EPYC™ 9005 processors, delivering breakthrough efficiency for generative-AI and HPC workloads. With support for expanded low-precision data types like FP4/FP6 and major gains in inference performance, the system enables ultra-fast AI inference alongside training. Built for efficiency and scalability, the system features industry-leading HBM capacity (288GB) and up to 8TB/s memory bandwidth, enabling rapid training and simulation of large AI models. while a direct GPU-to-GPU interconnect and modular 10U design ensure high throughput, simplified deployment, and optimal thermal performance, engineered for efficient generative-AI and large-model computing.

Beyond high-performance computing, ASUS also showcases the RS520QA-E13-RS8U, a 2U 4-node high-density server supporting CXL 2.0 for shared memory and ultra-low-latency data access, ideal for data-intensive HPC and AI factory environments. Completing the lineup, the RS720A-E13-RS8U and RS700A-E13-RS12U deliver balanced dual-socket performance, PCIe 5.0 expandability, and high memory capacity to meet the needs of virtualization, enterprise computing, and general-purpose AI deployments.

Comprehensive Intel Xeon 6 platform for AI and enterprise scalability

ASUS also presents its Intel lineup tailored for versatile enterprise and AI workloads. Leading the portfolio, ESC8000-E12P AI server supports up to eight dual-slot GPUs including Intel Gaudi® 3 PCIe® AI accelerators, paired with Intel Xeon 6 processors to deliver outstanding compute density and performance efficiency. Each Intel Gaudi 3 accelerator integrates 128GB of HBM2E memory and 3.7TB/s bandwidth, enabling sustained throughput for AI training, fine-tuning, and large-scale model execution. Featuring a PCIe 5.0 architecture with integrated Ethernet-based connectivity, the system provides optimized scale-out efficiency for enterprise AI infrastructures and RAG applications. For general-purpose deployments, the RS720-E12-RS24U offers a 2U dual-socket Intel Xeon 6 processors design optimized for balanced performance and expansion flexibility, while the RS700-E12-RS4U provides a compact, dual-socket Intel Xeon 6 processors high-I/O-density platform ideal for enterprise and virtualization workloads.

ASUS Tech Talks highlight industry collaboration

Reinforcing its commitment to open collaboration, ASUS is bringing together leading partners — including Intel, Vertiv, IBM, Micron, Western Digital, and WEKA — for ASUS Tech Talks, a series of in-booth sessions where industry experts share insights on cooling, storage, and compute innovations for next-generation AI infrastructure. These joint sessions emphasize ASUS’s role at the center of a vibrant technology ecosystem driving efficiency, scalability, and sustainability across AI data centers. Visitors are invited to join the discussions and meet ASUS experts at Booth #3732 to explore how co-innovation is powering the future of AI infrastructure.

About ASUS

ASUS is a global technology leader that provides the world’s most innovative and intuitive devices, components, and solutions to deliver incredible experiences that enhance the lives of people everywhere. With its team of 5,000 in-house R&D experts, the company is world-renowned for continuously reimagining today’s technologies. Consistently ranked as one of Fortune’s World’s Most Admired Companies, ASUS is also committed to sustaining an incredible future. The goal is to create a net zero enterprise that helps drive the shift towards a circular economy, with a responsible supply chain creating shared value for every one of us.

MELBOURNE, Australia and KYOTO, Japan, Nov. 21, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces the official opening of Telix Manufacturing Solutions (TMS) in Yokohama, Japan, the Company’s first cyclotron facility in the Asia Pacific region (APAC).

TMS Yokohama will enable Telix to provide greater access to radiopharmaceuticals for Japanese patients, initially through clinical supply of TLX250-CDx (a kidney cancer imaging candidate), with plans to supply other Telix investigational and future commercial products, including prostate and brain cancer precision diagnostics and therapies, subject to regulatory approval.

A commemorative lecture was held to mark the occasion, delivered by Professor Jun Hatazawa, Vice President of the Japan Isotope Association and Professor of the Next-Generation Cancer Therapy Research Division at Osaka University, entitled: ‘Trends and Challenges for the Future of Nuclear Medicine’.

Raphael Ortiz, CEO International Business and Japan President at Telix, stated, “The opening of TMS Yokohama is a significant milestone for Telix as it enhances our capacity to meet growing demand for radiopharmaceuticals in Japan and Asia Pacific. As the world’s second-largest nuclear medicine market, we have always considered Japan a key country in our clinical and commercial strategy. Today demonstrates our commitment to the Japanese community, to scientific excellence, and to the well-being of patients throughout the region.”

About Telix Manufacturing Solutions (TMS)

TMS is a global network of 39 manufacturing and distribution facilities across five continents, equipping Telix to deliver commercial and clinical doses to patients globally. Capabilities span isotope production, translational research and radiochemistry, antibody engineering, bioconjugation, and finished radiopharmaceutical manufacturing and distribution. Our TMS Brussels South site with nine GMP lines, clean rooms, a radiopharmacy, and two cyclotrons across a 30,000 sq ft site is one of Europe’s largest radiopharmaceutical production facilities. In the United States, through our RLS network we are delivering more than 2.5 million patient doses annually. Telix’s ARTMS QUANTM Irradiation System® (QIS®) advanced isotope production technology is being deployed at Telix cyclotron facilities worldwide, including select RLS radiopharmacies and TMS Brussels South and Yokohama.

About Telix Pharmaceuticals Limited

Telix is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. Telix is headquartered in Melbourne, Australia, with international operations in the United States, United Kingdom, Brazil, Canada, Europe (Belgium and Switzerland), and Japan. Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (NASDAQ: TLX).

Visit www.telixpharma.com or jp.telixpharma.com for further information about Telix, including details of the latest share price, ASX and U.S. Securities and Exchange Commission (SEC) filings, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on LinkedIn, X and Facebook

Telix Investor Relations (Global)

Ms. Kyahn Williamson
Telix Pharmaceuticals Limited
SVP Investor Relations and Corporate Communications
Email: kyahn.williamson@telixpharma.com

Legal Notices

Cautionary Statement Regarding Forward-Looking Statements. 

You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our Annual Report on Form 20-F filed with the SEC, or on our website.

The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification.  To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement.

This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as “may”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “outlook”, “forecast” and “guidance”, or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix’s good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix’s business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix’s business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress, completion and results of Telix’s preclinical and clinical trials, and Telix’s research and development programs; Telix’s ability to advance product candidates into, enroll and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix’s product candidates, manufacturing activities and product marketing activities; Telix’s sales, marketing and distribution and manufacturing capabilities and strategies; the commercialization of Telix’s product candidates, if or when they have been approved; Telix’s ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix’s expenses, future revenues and capital requirements; Telix’s financial performance; developments relating to Telix’s competitors and industry; the anticipated impact of U.S. and foreign tariffs and other macroeconomic conditions on Telix’s business; and the pricing and reimbursement of Telix’s product candidates, if and after they have been approved. Telix’s actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements.

Trademarks and Trade Names. All trademarks and trade names referenced in this press release are the property of Telix Pharmaceuticals Limited (Telix) or, where applicable, the property of their respective owners. For convenience, trademarks and trade names may appear without the ® or ™ symbols. Such omissions are not intended to indicate any waiver of rights by Telix or the respective owners. Trademark registration status may vary from country to country. Telix does not intend the use or display of any third-party trademarks or trade names to imply any affiliation with, endorsement by, or sponsorship from those third parties.

©2025 Telix Pharmaceuticals Limited. All rights reserved.